99
Participants
Start Date
November 7, 2019
Primary Completion Date
July 2, 2027
Study Completion Date
June 11, 2035
ACE-536
Specified dose on specified days
WITHDRAWN
Local Institution - 700, Beirut
RECRUITING
Azienda Ospedaliero Universitaria S. Luigi Gonzaga, Orbassano
RECRUITING
Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital, Bangkok
RECRUITING
Ramathibodi Hospital, Mahidol University, Phyathai
RECRUITING
Siriraj Hospital Mahidol University, Bangkok
RECRUITING
Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite, Genoa
COMPLETED
Local Institution - 401, Izmir
RECRUITING
Universitätsklinikum Essen, Essen
RECRUITING
AOU dell'Universita degli Studi della Campania Luigi Vanvitelli, Napoli
RECRUITING
Universitatsklinikum Ulm, Ulm
COMPLETED
Local Institution - 601, Los Angeles
RECRUITING
Post Graduate Institute of Child Health, Noida
RECRUITING
MCGM - Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & BMT Centre, Borivali (E), Mumbai
RECRUITING
Kingsway Hospitals, Nagpur
RECRUITING
Kamala Hospital and Research Center, Hyderabad
RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou
RECRUITING
Nanfang Hospital, Southern Medical University, Guangzhou
RECRUITING
Shenzhen Second People's Hospital, Shenzhen
NOT_YET_RECRUITING
Local Institution - 904, Nanning
RECRUITING
The First Affiliated Hospital of Guangxi Medical University, Nanning
RECRUITING
West China Hospital - Sichuan University, Chengdu
RECRUITING
Christian Medical College & Hospital, Vellore
WITHDRAWN
Local Institution - 803, Kolkata
RECRUITING
New York Presbyterian Hospital, New York
RECRUITING
"General Children's Hospital Agia Sophia", Athens
RECRUITING
Ospedale Pediatrico Bambino Gesù IRCCS, Rome
Lead Sponsor
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
INDUSTRY
Celgene
INDUSTRY